MicroRNAs as Therapeutic Targets and Colorectal Cancer Therapeutics
- 30 August 2016
- book chapter
- review article
- Published by Springer Science and Business Media LLC
- Vol. 937, 239-247
- https://doi.org/10.1007/978-3-319-42059-2_13
Abstract
The diagnosis and treatment of colorectal cancer (CRC) have improved greatly over recent years; however, CRC is still one of the most common cancers and a major cause of cancer death worldwide. Several recently developed drugs and treatment strategies are currently in clinical trials; however, there is still a compelling need for novel, highly efficacious therapies. MicroRNAs (miRNAs) are short non-coding RNAs consisting of 20–25 nucleotides that regulate post-transcriptional gene expression by binding to the 3′-untranslated region of mRNAs. miRNAs are known to regulate cancer pathways and to be expressed aberrantly in cancer. Since their initial discovery, a large number of miRNAs have been identified as oncogenes, whereas others function as tumor suppressors. Furthermore, signaling pathways that are important in CRC (e.g. the WNT, MAPK, TGF-β, TP53 and PI3K pathways) are regulated by miRNAs. A single miRNA can simultaneously regulate several target genes and pathways, indicating the therapeutic potential of miRNAs in CRC. However, significant obstacles remain to be overcome, such as an efficient miRNA delivery system, and the assessment of safety and side effects. Thus, miRNA therapy is still developing and possesses great potential for the treatment of CRC. In this chapter, we focus on miRNAs related to CRC and summarize previous studies that emphasize the therapeutic aspects of miRNAs in CRC.Keywords
This publication has 44 references indexed in Scilit:
- MicroRNA-32 (miR-32) regulates phosphatase and tensin homologue (PTEN) expression and promotes growth, migration, and invasion in colorectal carcinoma cellsMolecular Cancer, 2013
- MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasisGut, 2012
- High Let-7a MicroRNA Levels in KRAS-Mutated Colorectal Carcinomas May Rescue Anti-EGFR Therapy Effects in Patients with Chemotherapy-Refractory Metastatic DiseaseThe Oncologist, 2012
- The Role of MicroRNAs in Colorectal CancerThe Cancer Journal, 2012
- MicroRNA-21 induces stemness by downregulating transforming growth factor beta receptor 2 (TGF R2) in colon cancer cellsCarcinogenesis: Integrative Cancer Research, 2011
- Asymmetry-Defective Oligodendrocyte Progenitors Are Glioma PrecursorsCancer Cell, 2011
- MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2)Proceedings of the National Academy of Sciences of the United States of America, 2010
- Dividing cellular asymmetry: asymmetric cell division and its implications for stem cells and cancerGenes & Development, 2009
- The noncoding RNA, miR‐126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3‐kinase signaling and is frequently lost in colon cancersGenes, Chromosomes and Cancer, 2008
- Transactivation of miR-34a by p53 Broadly Influences Gene Expression and Promotes ApoptosisMolecular Cell, 2007